ContractResearch Services Agreement • August 23rd, 2012 • Audeo Oncology, Inc. • Pharmaceutical preparations
[***] DENOTES CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT
CLINICAL RESEARCH SERVICES AGREEMENTClinical Research Services Agreement • August 23rd, 2012 • Audeo Oncology, Inc. • Pharmaceutical preparations • England
• Alchemia Oncology Pty Ltd. Incorporated in Australia, having its principal place of business at 31 HI-Tech Court, Brisbane Technology Court, Eight Mile Plains, Queensland, Australia (“Sponsor”)
GENERAL SERVICES AGREEMENT BioClinica Agreement #33602General Services Agreement • August 23rd, 2012 • Audeo Oncology, Inc. • Pharmaceutical preparations • New York
This General Services Agreement (this “Agreement”) effective as of the last date of signature hereof (the “Effective Date”), by and between BIOCLINICA, INC., a Delaware Corporation, with its principal place of business at 826 Newtown-Yardley Road, Newtown, Pennsylvania, 18940-1721 (“BIOCLINICA”) and Alchemia Oncology Pty Ltd. with its principal place of business at 31 Hi-Tech Court, Brisbane Technology Court, Eight Mile Plains QLD, Australia (“ALCHEMIA”). BIOCLINICA and ALCHEMIA are individually referred to as a “Party” and collectively as the “Parties”.
